CliffBio
small molecule

POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9%

POTASSIUM CHLORIDE; SODIUM CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand namePOTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9%
Active ingredientPOTASSIUM CHLORIDE; SODIUM CHLORIDE
Strength150MG/100ML;900MG/100ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJune 2021
Marketing statusRX

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.